• BMS-345541 hydrochloride: IKK Assay Guide

  2026-09-13

  Use BMS-345541 hydrochloride as a selective IKK inhibitor to separate NF-κB-dependent inflammatory signaling from downstream cell-death phenotypes. This workflow combines concentration, solubility, timing, and orthogonal readout guidance for inflammation research, T-ALL models, and RIPK1-focused experiments.

• Artemisinin, NRF2, and Ferroptosis in Diabetic Cognition

  2026-09-12

  Wang et al. showed that artemisinin improved learning and memory in streptozotocin-induced type 2 diabetes mellitus mice while reducing hippocampal oxidative injury and ferroptosis-related changes. Pharmacological blockade of NRF2 with ML385 and induction of ferroptosis with erastin weakened these benefits, supporting an NRF2-dependent mechanism that links redox control to diabetic cognitive dysfunction.

• Bromodomain Inhibitor, (+)-JQ1: Assay Guide

  2026-09-11

  A practical, scenario-based guide to using Bromodomain Inhibitor, (+)-JQ1 (SKU A1910) in viability, proliferation, and apoptosis workflows. It connects BET biology with solvent control, time-course design, endpoint selection, data interpretation, and research-grade product selection.

• ML365: TASK1 Inhibitor for Ion Channel Research

  2026-09-11

  ML365, also known as 2-methoxy-N-(3-(3-methylbenzamido)phenyl)benzamide, is a potent TASK1 potassium channel inhibitor with nanomolar assay activity. Product data and a 2024 aged-mouse study support its use in ion channel pharmacology research and exploratory neuroinflammation experiments, while direct TASK1 causality in postoperative cognitive impairment remains unproven.

• FerroOrange: Translating Fe²⁺ Signals in Ferroptosis

  2026-09-10

  Ferroptosis is not simply an endpoint of neuronal injury; it is a dynamic intersection of iron handling, lipid damage, inflammation, and cellular stress. This thought-leadership guide explains how FerroOrange can help translational researchers connect live-cell Fe²⁺ measurements with the Cdk5–AMPK evidence emerging from ischemic-stroke models, while preserving appropriate assay boundaries.

• Isochlorogenic Acid A Disrupts the HBV Life Cycle

  2026-09-10

  The reference study shows that isochlorogenic acid A suppresses hepatitis B virus replication through coordinated effects on HO-1-mediated reactive oxygen species regulation, viral gene expression, cccDNA-associated signals, capsid formation, and envelopment. Its value lies in connecting redox biology with several distinct stages of HBV morphogenesis, while also defining experimental readouts for testing this mechanism.

• RCN2 Drives ESCC Metastasis and Cisplatin Resistance

  2026-09-09

  This study identifies RCN2 as a driver of esophageal squamous cell carcinoma metastasis and cisplatin resistance through UBR5-dependent ubiquitination and degradation of PPP2CA. Its integrated clinical, multi-omic, biochemical, and animal-model evidence defines an RCN2–UBR5–PPP2CA–PI3K-AKT axis that may help explain treatment failure in advanced ESCC.

• SM-102 for mRNA Delivery: Practical LNP Guide

  2026-09-09

  SM-102 offers a practical ionizable-lipid starting point for lipid nanoparticle workflows spanning mRNA vaccine development, cell assays, and formulation screening. This guide connects product handling, reproducible mixing, data-driven comparison, and troubleshooting so researchers can separate lipid performance from process variability.

• Lipo3K Transfection Reagent for GBM Assays

  2026-09-08

  Use Lipo3K Transfection Reagent to build efficient PXDN knockdown, LDHA rescue, and DNA–siRNA co-transfection workflows in glioblastoma models. Its low-toxicity profile, enhancer option for plasmids, and compatibility with serum-containing media help connect mechanistic gene studies with reproducible metabolic assays.

• HyperScribe All in One mRNA Synthesis Kit Plus 1 Guide

  2026-09-08

  Build capped, modified, and polyadenylated mRNA in one coordinated workflow for translation studies, RNA vaccine development, and RNA interference (RNAi) experiments. This guide explains how ARCA capping, 5mCTP, ψUTP, DNase treatment, and poly(A) tailing work together, with practical controls and troubleshooting for reproducible results.

• PPP1R3G/PP1γ Activates RIPK1 Cell Death

  2026-09-07

  Du et al. identify PPP1R3G as the regulatory subunit that recruits PP1γ to dephosphorylate and activate RIPK1, thereby enabling RIPK1-dependent apoptosis and type I necroptosis. The study combines sensitized CRISPR screening, genetic rescue, phosphosite bypass, and mouse experiments to connect RIPK1 regulation with TNF-driven inflammatory pathology.

• CP-673451: A Precision Lens on PDGFR in Glioma

  2026-09-07

  CP-673451 offers a selective, mechanism-focused way to interrogate PDGFRα/β signaling, angiogenesis, and tumor biology. Combined with ATRX stratification and temozolomide-response analysis, it can help translational researchers distinguish target engagement from context-dependent therapeutic vulnerability.

• ML365 and NLRP3 Signaling in Aged-Mouse POCD

  2026-09-05

  A 2024 Brain Research study reports that ML365 pretreatment reduced postoperative cognitive impairment in aged mice after exploratory laparotomy, coinciding with lower hippocampal NLRP3 inflammasome signaling, less tissue injury, and reduced oxidative stress. The work is notable for linking K2P channel pharmacology with postoperative neuroinflammation, while its findings still require direct target-engagement and translational validation.

• RWJ 67657: From Blockade to Signal Reset

  2026-09-04

  RWJ 67657 (JNJ-3026582) is a selective p38α/β inhibitor for dissecting inflammatory signaling. This article connects its TNF-alpha activity with new structural insights into p38α dephosphorylation and shows how to design more informative assays.

• ARCA Cy5 EGFP mRNA: Delivery Assay Guide

  2026-09-04

  Track both mRNA entry and functional protein expression in the same mammalian-cell experiment. This guide shows how to use a Cy5-labeled, 5-methoxyuridine modified reporter to compare delivery systems, diagnose nonproductive uptake, and connect bench assays with mRNA-LNP development.

8139 records 1/543 page Next 12345 下5页 Last page